CFS
VNDA icon

CGC Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History

CGC Financial Services’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306 Hold
50
– – ﹤0.01% 327
2026
Q1 		$346 Hold
50
– – ﹤0.01% 320
2025
Q4 		$441 Hold
50
– – ﹤0.01% 323
2025
Q3 		$250 Hold
50
– – ﹤0.01% 331
2025
Q2 		$236 Hold
50
– – ﹤0.01% 321
2025
Q1 		$230 Hold
50
– – ﹤0.01% 319
2024
Q4 		$240 Hold
50
– – ﹤0.01% 330
2024
Q3 		$235 Hold
50
– – ﹤0.01% 328
2024
Q2 		$283 Hold
50
– – ﹤0.01% 328
2024
Q1 		$206 Hold
50
– – ﹤0.01% 341
2023
Q4 		$211 Hold
50
– – ﹤0.01% 354
2023
Q3 		$216 Hold
50
– – ﹤0.01% 314
2023
Q2 		$330 Buy
+50
New +$321 ﹤0.01% 333

Other funds holding VNDA

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return